
Ga-PSMA PET MRI offers nearly 22 percent higher sensitivity for localized prostate cancer and comparable specificity to multiparametric MRI, according to a recently published prospective study.

Ga-PSMA PET MRI offers nearly 22 percent higher sensitivity for localized prostate cancer and comparable specificity to multiparametric MRI, according to a recently published prospective study.

Catch up on the top radiology content of the past week.

For men with PI-RADS 3 lesions, PRIMARY scores of 4-5 with PET/MRI had a sensitivity rate of 87.5 percent for clinically significant prostate cancer, according to newly published research.

In a study of patients who had lumbar spine MRI exams at 0.55T, 1.5T and 3T, researchers found that 0.55T MRI provided acceptable diagnostic quality across all sequences for varying pathologies including degenerative joint disease, compression fractures and osseous metastatic disease.

Catch up on the top radiology content of the past week.

Emphasizing optimal balancing of patient safety and image quality, these authors discuss the impact of the specific absorption rate and B1+rms parameters upon radiofrequency exposure with MRI exams.

Amid new research insights and advances in the management of patients with prostate cancer, Daniel Spratt, M.D., shared his observations in an interview on the emerging role and impact of PSMA-PET imaging.

Emerging research with low-field MRI shows that persistently moderate to severe opacities were a common finding in patients up to two years after having acute COVID-19 pneumonia.

Catch up on the top radiology content of the past week.

Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.

In a study of nearly 2,500 women with BRCA1 or BRCA2 sequence variations, researchers found that MRI surveillance led to a 3.2 percent breast cancer mortality risk at 20 years in contrast to a 14.9 percent mortality risk for those who did not have MRI surveillance.

Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).

Catch up on the most-well viewed radiology content in February 2024.

A new meta-analysis noted pooled sensitivity and specificity rates of 83 percent and 91 percent, respectively, for the use of non-contrast abbreviated MRI in surveillance of hepatocellular carcinoma (HCC).

Catch up on the top AI-related news and research in radiology over the past month.

For patients with suspected acute stroke, researchers noted higher image quality for deep learning-accelerated MRI, which can be completed over 11 minutes sooner than similar sequences for conventional MRI.

Catch up on the top radiology content of the past week.

For people with COVID-19 related brain fog, emerging dynamic contrast-enhanced MRI (DCE-MRI) research findings revealed blood-brain barrier disruption in multiple brain regions, including temporal lobes and the frontal cortex, up to a year after active infection.

Offering rapid automated segmentation of brain structures, the ClearPoint 2.2 software reportedly enhances visualization for a variety of targeted, MRI-guided procedures.

Catch up on the top radiology content of the past week.

For women with dense breasts, only 25 percent of breast radiologists are confident in the use of mammography for diagnosing invasive lobular carcinoma, according to newly published survey results from the Society of Breast Imaging.

The adjunctive use of AI software led to 16 percent and 10 percent increases in sensitivity rates for the detection of ARIA-E and ARIA-H, respectively, in patients with Alzheimer’s disease, according to newly published research.

In an analysis of repeat prostate cancer screening, researchers noted no suspicious MRI findings for over 86 percent of men who had PSA levels of 3 ng/mL or greater at a second prostate cancer screening.

Catch up on the top radiology content of the past week.

For the detection of nodal metastases in patients with early-stage cervical cancer, 18F FDG PET-CT offered a sensitivity rate that was double that of CT and 32 percent higher than MRI, according to newly published research.